Shock, Septic Clinical Trials

8 recruitingLast updated: May 21, 2026

There are 8 actively recruiting shock, septic clinical trials across 9 countries. Studies span Not Applicable, Phase 3. Top locations include Berlin, Germany, Copenhagen, Denmark, Dessau, Germany. Updated daily from ClinicalTrials.gov.


Shock, Septic Trials at a Glance

8 actively recruiting trials for shock, septic are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Berlin, Copenhagen, and Dessau. Lead sponsors running shock, septic studies include Hospital General de México Dr. Eduardo Liceaga, International Centre for Diarrhoeal Disease Research, Bangladesh, and Assistance Publique - Hôpitaux de Paris.

Browse shock, septic trials by phase

About Shock, Septic Clinical Trials

Looking for clinical trials for Shock, Septic? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Shock, Septic trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Shock, Septic clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Not Applicable

Early Intravenous Hydrocortisone in Sepsis

Sepsis, SevereShock, Septic
Siriraj Hospital230 enrolled1 locationNCT06217939
Recruiting

Early Severe Illness TrAnslational BioLogy InformaticS in Humans

SepsisInflammationCritical Illness+6 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1,000 enrolled1 locationNCT05591924
Recruiting
Phase 3

Early Initiated Vasopressor Therapy in the Emergency Department

HypotensionHypotension SymptomaticShock+5 more
Odense University Hospital320 enrolled8 locationsNCT05931601
Recruiting
Phase 3

Management of Shock in Children With SAM or Severe Underweight and Diarrhea

blood transfusionShock, SepticShock Hypovolemic+2 more
International Centre for Diarrhoeal Disease Research, Bangladesh135 enrolled1 locationNCT04750070
Recruiting

Types of Photoplethysmographic Waves in Adult Patients with Septic Shock

Shock, SepticPhotoplethysmographyWaveform
Hospital General de México Dr. Eduardo Liceaga116 enrolled1 locationNCT06786364
Recruiting
Not Applicable

Hemodynamic Phenotype-Based,Capillary Refill Time-Targeted Resuscitation In Early Septic Shock:ANDROMEDA-SHOCK-2

Shock, SepticIntensive care Unit acquired weakness
Assistance Publique - Hôpitaux de Paris180 enrolled1 locationNCT06062303
Recruiting

Pituitary Function After Recovery From Septic Shock Among ICU Survivors

HypopituitarismShock, SepticPituitary Dysfunction
Sanjay Gandhi Postgraduate Institute of Medical Sciences90 enrolled2 locationsNCT05990491
Recruiting

Study of Progression of Community Acquired Pneumonia in the Hospital in Patients With More Severe Preexisting Diseases and Immunosuppression

SepsisPneumoniaShock, Septic
Pneumonia Research Network on Genetic Resistance and Susceptibility for the Evolution of Severe Seps300 enrolled10 locationsNCT05688774